CorestemChemon Partners with ATG Lifetech to Expand Global CRO Footprint
CorestemChemon, a South Korea–based GLP-certified preclinical CRO, has partnered with ATG Lifetech to co-develop advanced transcriptome and organoid-based platforms, aiming to deliver precision-driven, next-gen preclinical solutions to global pharma and biotech clients.
CorestemChemon Partners With ATG Lifetech | 21/07/2025 | By Mrinmoy Dey | 153
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy